跳至主要内容
临床试验/EUCTR2012-002244-25-GB
EUCTR2012-002244-25-GB进行中(未招募)1 期

Prospective feasibility study for the evaluation of indocyanine green and near-infrared imaging in sentinel lymph node biopsy for cutaneous melanoma patients: The RED-GREEN-BLUE melanoma study. - Feasibility of indocyanine green in sentinel node biopsy in melanoma

orfolk & Norwich University Hospital0 个研究点目标入组 60 人开始时间: 2012年6月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Any patients eligible for Sentinel lymph node biopsy for cutaneous melanoma
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 25

排除标准

  • 1. Patients unable to give informed consent.
  • 2. Patients with reduced mental capacity to give informed consent.
  • 3. Vulnerable adults, children, prisoners.
  • 4. Patients who already have undergone lymph node dissection in a potentially draining lymph node field.
  • 5. Patients where the preoperative lymphoscintigraphy has failed.
  • 6. Patients who are allergic to indocyanine green
  • 7. Pregnant or lactating women
  • 8. Patients with hyperthyroidism or with toxic thyroid adenomas
  • 9. Palpable lymph nodes in draining regional nodal field

研究者

发起方
orfolk & Norwich University Hospital

相似试验